Back

Cardiac Myosin inhibitor improves mid-ventricular obstruction in hypertrophic cardiomyopathy

29 August 2026 (12:20 - 12:30)
Organised by: Logo
Congress Presentation Part of: New insights into hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Luan Lina

Shanghai Geriatric Medical Center, Shanghai (China)

4 More presentations in this session

Presentation thumbnail
Mavacamten versus septal reduction therapy in obstructive hypertrophic cardiomyopathy: a propensity score-matched analysis from a global real-world network
Ms Y. Srivastava (IN)
Abstract Slides
Presentation thumbnail
Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy
Doctor A. Bakalakos (London, GB)
Abstract
Presentation thumbnail
Extracellular vesicles in hypertrophic cardiomyopathy patients
Associate Professor M. Ruscica (Milan, IT)
Abstract
Presentation thumbnail
Family screening outcomes in gene-elusive HCM
Doctor P. Martin Marin (London, GB)
Abstract

Access the full session

Session thumbnail
New insights into hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 12:20 CET
You may be interested in
thumbnail
Congress Presentation
The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment
12 December 2024
thumbnail
Congress Presentation
4D-flow cardiac magnetic resonance analysis of left ventricular blood flow dynamics in mid-ventricular obstructive hypertrophic cardiomyopathy
3 September 2019
thumbnail
Webinar
The spectrum of management options for the left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
28 October 2020
thumbnail
Congress Presentation
Expanding the role of myosin inhibition: mavacamten in apical hypertrophic cardiomyopathy with mid-ventricular obstruction
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources